Drug Combo Fights Tough-to-Treat Hepatitis C

This article mainly deals with the combination of two drugs, ribavirin and Infergen, to combat hepatitis C in patients who were unresponsive to other therapies. In a disease that currectly affects 3.9 million Americans and is growing at a rate of 50,000 Americans per year, it is important to find new techniques and medicines to combat this unresponsiveness. As a side note, there was another study done on people with severe hepatitis C and severe liver damage that after therapy the liver damage "greatly improved". This just shows me that there need to be several medicines to combat a particular illness since there is a lot of variation from person to person.

http://health.msn.com/healthnews/articlepage.aspx?cp-documentid=100147721